HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Natsume Selected Research

ranimustine

10/2013[Chemotherapy for malignant gliomas: an update].
7/2009Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
7/2007Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.
7/2006[Glioma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Natsume Research Topics

Disease

60Neoplasms (Cancer)
08/2022 - 09/2005
60Glioma (Gliomas)
06/2022 - 09/2005
33Glioblastoma (Glioblastoma Multiforme)
04/2021 - 07/2007
16Brain Neoplasms (Brain Tumor)
01/2020 - 04/2006
7Meningioma (Meningiomas)
11/2021 - 04/2005
6Carcinogenesis
06/2022 - 10/2009
5Spinal Cord Injuries (Spinal Cord Injury)
02/2021 - 10/2007
3Moyamoya Disease (Moya-Moya Disease)
08/2021 - 01/2020
3Gliosis
12/2014 - 01/2009
3Testicular Neoplasms (Testicular Cancer)
06/2010 - 06/2008
2Microsatellite Instability
08/2022 - 05/2020
2Thrombosis (Thrombus)
08/2021 - 01/2021
2Germinoma
01/2021 - 01/2021
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021 - 10/2020
2Ependymoma
01/2021 - 03/2009
2Necrosis
06/2020 - 12/2018
2Neuroepithelial Neoplasms (Gliomatosis Cerebri)
04/2020 - 05/2019
2Inflammation (Inflammations)
12/2018 - 05/2018
2Neoplasm Metastasis (Metastasis)
12/2018 - 05/2006
2Melanoma (Melanoma, Malignant)
05/2018 - 08/2003
2Brain Ischemia (Cerebral Ischemia)
11/2017 - 11/2010
2Leukemia
01/2017 - 03/2013
2Lymphoma (Lymphomas)
01/2017 - 11/2011
2Infections
01/2015 - 07/2014
2Ischemic Stroke
11/2010 - 08/2007
2Cognitive Dysfunction
11/2010 - 08/2007
2Brain Stem Neoplasms (Brain Stem Tumor)
07/2009 - 03/2009
2Astrocytoma (Pilocytic Astrocytoma)
07/2008 - 08/2007
1Central Nervous System Neoplasms
04/2021

Drug/Important Bio-Agent (IBA)

20Temozolomide (Temodar)FDA LinkGeneric
05/2020 - 09/2005
11Proteins (Proteins, Gene)FDA Link
08/2019 - 01/2004
10Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 03/2013
9DNA (Deoxyribonucleic Acid)IBA
08/2021 - 08/2007
8Interferon-betaIBA
05/2020 - 08/2003
7InterferonsIBA
06/2020 - 07/2006
6epidermal growth factor receptor VIIIIBA
06/2020 - 12/2010
6MethyltransferasesIBA
05/2020 - 04/2008
6Alkylating AgentsIBA
10/2013 - 09/2005
6AntigensIBA
07/2012 - 06/2008
5CytokinesIBA
08/2021 - 04/2005
5Chimeric Antigen ReceptorsIBA
06/2020 - 01/2013
5ErbB Receptors (EGF Receptor)IBA
06/2020 - 04/2006
5Peptides (Polypeptides)IBA
01/2019 - 12/2003
5Liposomes (Liposome)IBA
01/2014 - 08/2003
4Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2010
4Histones (Histone)IBA
01/2020 - 03/2009
4ranimustineIBA
10/2013 - 07/2006
3Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
09/2021 - 03/2012
3Polycomb Repressive Complex 2IBA
10/2019 - 07/2009
3Pharmaceutical PreparationsIBA
08/2019 - 09/2005
3Biological ProductsIBA
01/2017 - 07/2013
3GuanineIBA
01/2017 - 04/2012
3O(6)-Methylguanine-DNA MethyltransferaseIBA
01/2014 - 08/2007
3Antineoplastic Agents (Antineoplastics)IBA
10/2013 - 09/2005
2Immune Checkpoint InhibitorsIBA
08/2022 - 12/2016
2ParaffinIBA
08/2022 - 07/2014
2Formaldehyde (Formol)FDA Link
08/2022 - 07/2014
2poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
01/2022 - 01/2015
2RNA (Ribonucleic Acid)IBA
11/2021 - 01/2018
2A-Form DNA (A-DNA)IBA
09/2021 - 01/2014
2GangliosidesIBA
09/2021 - 06/2015
2GD3 ganglioside (GD(3))IBA
08/2021 - 06/2015
2MicroRNAs (MicroRNA)IBA
04/2021 - 12/2009
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 01/2021
2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
04/2020 - 05/2019
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2020 - 04/2006
2AntibodiesIBA
05/2018 - 12/2016
2Phosphotransferases (Kinase)IBA
01/2018 - 06/2015
2Oxygen (Dioxygen)IBA
11/2017 - 03/2013
2IfosfamideFDA LinkGeneric
01/2017 - 11/2011
2Carboplatin (JM8)FDA LinkGeneric
01/2017 - 11/2011
2Etoposide (VP 16)FDA LinkGeneric
01/2017 - 11/2011
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2017 - 11/2011
2Glutamic Acid (Glutamate)FDA Link
12/2014 - 06/2014
2NimustineIBA
10/2013 - 07/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 04/2005
2Small Interfering RNA (siRNA)IBA
06/2013 - 07/2007
2Green Fluorescent ProteinsIBA
06/2013 - 03/2012
2Free Radical ScavengersIBA
11/2010 - 08/2007
2EdaravoneIBA
11/2010 - 08/2007
2DecitabineFDA Link
03/2009 - 06/2008
1alpha-hydroxyglutarateIBA
06/2022
1Carmustine (FIVB)FDA Link
01/2022
1Thiostrepton (Gargon)IBA
11/2021
1Indicators and Reagents (Reagents)IBA
11/2021
1src-Family KinasesIBA
09/2021
1Matrix Metalloproteinases (MMPs)IBA
09/2021
1ChemokinesIBA
08/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
08/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2021
1Transcription Factors (Transcription Factor)IBA
02/2021

Therapy/Procedure

27Therapeutics
01/2021 - 07/2007
22Radiotherapy
06/2022 - 04/2006
17Drug Therapy (Chemotherapy)
06/2022 - 04/2006
7Immunotherapy
01/2020 - 06/2008
3Precision Medicine
01/2021 - 04/2017
3Craniotomy
10/2019 - 07/2014
2Ligation
04/2020 - 05/2019
2Aftercare (After-Treatment)
07/2015 - 08/2003
2Spinal Fusion (Spondylosyndesis)
01/2014 - 01/2012